Priority Medical

CLINICAL-TRIALS

Read EPM Magazine online
CLINICAL-TRIALS

Read EPM Magazine online

The pharmaceutical industry is a dynamic and everevolving field, with constant advancements in technology, regulations, and treatment methodologies. For professionals and enthusiasts alike, staying updated on the latest developments is crucial. One reliable source for this information is the European Pharmaceutical Manufacturer (EPM) Magazine..

Bayer applies for EU approval of menopause drug elinzanetant
CLINICAL-TRIALS

Bayer applies for EU approval of menopause drug elinzanetant

Bayer, one of the world’s leading pharmaceutical companies, has made a significant move in the treatment of menopausal symptoms by submitting a marketing authorization application to the European Medi..

Council Post: Unlocking Growth And Ensuring Compliance: Data Management In Pharma
CLINICAL-TRIALS

Council Post: Unlocking Growth And Ensuring Compliance: Data Management In Pharma

The pharmaceutical industry is one of the most dataintensive sectors globally, with a vast array of information generated from research and development to patient records. Effective data management has become a crucial aspect of this industry, not only to ensure compliance with stringent regulations but also to unlock growth opportunities..

Pharmaceutical

Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal

A Major Move in the World of Neuroscience and Rare Diseases In a significant development in the pharmaceutical industry, Danish company Lundbeck A/S has announced its intention to acquire U.S.

Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal
Pharmaceutical

Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?

In a significant development that has sent shockwaves through the healthcare sector, Denmarkbased H. Lundbeck A/S has announced its intention to acquire Longboard Pharmaceuticals, Inc.

Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?
Pharmaceutical

Inventiva secures up to $380m for MASH treatment lanifibranor

In a significant development in the world of biotechnology, Inventiva, a French pharmaceutical company, has secured up to €348 million ($380 million) in financing to support the completion of a Phase .

Inventiva secures up to $380m for MASH treatment lanifibranor
Mental Health

Do AI mental health apps really work?

The Rise of AI in Mental Health In recent years, the world has witnessed a significant shift in how we approach mental health care.

Do AI mental health apps really work?
Pharmaceutical

Protheragen Launches Advanced Disease Model Platform for Rare Disease Research

In a significant move towards advancing rare disease research, Protheragen, a leading Contract Research Organization (CRO) specializing in rare disease research, has unveiled a groundbreaking disease .

Protheragen Launches Advanced Disease Model Platform for Rare Disease Research
Health Services

New gynecologic oncology services advance patient care

In a significant move to enhance the management and treatment of gynecologic cancers, the Samaritan Cancer Program has expanded its specialty services to include comprehensive gynecologic oncology car.

New gynecologic oncology services advance patient care
Pharmaceutical

Centessa Pharmaceuticals Plc (CNTA): A Small-Cap Leader in Clinical-Stage Biotech

Introduction In the everevolving landscape of pharmaceuticals, innovation and potential for growth are key factors driving the stock market.

Centessa Pharmaceuticals Plc (CNTA): A Small-Cap Leader in Clinical-Stage Biotech
Pharmaceutical

The Manufacturers Life Insurance Company Acquires 32,846 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)

By: Newspaper Journalist In a significant move in the world of pharmaceuticals, The Manufacturers Life Insurance Company has increased its stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA) by 30.

The Manufacturers Life Insurance Company Acquires 32,846 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)
Pharmaceutical

AI in Pharma Shows Promise With Faster Development, Lower Costs

Artificial intelligence (AI) is transforming the pharmaceutical industry, compressing timelines and potentially slashing drug prices.

AI in Pharma Shows Promise With Faster Development, Lower Costs